» Articles » PMID: 17605300

Widespread, Exceptionally High Levels of Histone H3 Lysine 4 Trimethylation Largely Mediate "privileged" Gene Expression

Overview
Journal Gene Expr
Specialty Molecular Biology
Date 2007 Jul 4
PMID 17605300
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the molecular determinants for sustained high-level expression of "privileged" genes, defined as the 0.03% most highly expressed genes within any specific cell. We identified histone modifications by chromatin immunoprecipitation analyses on Keratin 8, the most highly expressed gene in the human breast cancer cell line, MCF-7, based on serial analysis of gene expression. Quantitative comparisons to the "normal" counterpart cell line, MCF-10A, expressing 350-fold lower levels of Keratin 8 and other breast cancer cell lines expressing higher levels were performed using real-time PCR. Extraordinarily high levels of trimethyl histone H3 lysine 4 (H3K4) were found primarily in the first intron of the Keratin 8 gene stretching from 400 to 2000 bp downstream from the promoter in all breast cancer cells lines but not in MCF-10A cells. The highest levels of histone H3K4 trimethylation in MCF-7 cells ranged from 70% to 80% over input within 1200 bp of this region. Knockdown of mixed-lineage leukemia (MLL), the specific methyltransferase for histone H3K4, with MLL-specific siRNA decreased histone H3K4 trimethylation on the Keratin 8 gene and decreased Keratin 8 mRNA levels. Histone H3K4 trimethylation mediates approximately 86% of the elevated, sustained expression of the Keratin 8 gene in MCF-7 cells.

Citing Articles

Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer.

Deb M, Kar S, Sengupta D, Shilpi A, Parbin S, Rath S Cell Mol Life Sci. 2014; 71(18):3439-63.

PMID: 24676717 PMC: 11113154. DOI: 10.1007/s00018-014-1605-4.


Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.

Templeton N, Senzer N J Genet Syndr Gene Ther. 2012; (S5).

PMID: 23087840 PMC: 3476733. DOI: 10.4172/2157-7412.s5-002.


Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene.

Naito M, Bomsztyk K, Zager R Am J Pathol. 2008; 174(1):54-62.

PMID: 19095962 PMC: 2631318. DOI: 10.2353/ajpath.2009.080602.


Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure.

Naito M, Bomsztyk K, Zager R J Am Soc Nephrol. 2008; 19(7):1321-30.

PMID: 18417719 PMC: 2440304. DOI: 10.1681/ASN.2007121368.

References
1.
Stewart M, Li J, Wong J . Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol. 2005; 25(7):2525-38. PMC: 1061631. DOI: 10.1128/MCB.25.7.2525-2538.2005. View

2.
Milne T, Dou Y, Martin M, Brock H, Roeder R, Hess J . MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci U S A. 2005; 102(41):14765-70. PMC: 1253553. DOI: 10.1073/pnas.0503630102. View

3.
Brotherick I, Robson C, Browell D, Shenfine J, White M, Cunliffe W . Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression. Cytometry. 1998; 32(4):301-8. View

4.
Hediger F, Gasser S . Heterochromatin protein 1: don't judge the book by its cover!. Curr Opin Genet Dev. 2006; 16(2):143-50. DOI: 10.1016/j.gde.2006.02.013. View

5.
Kralovich K, Li L, Hembrough T, Webb D, Karns L, Gonias S . Characterization of the binding sites for plasminogen and tissue-type plasminogen activator in cytokeratin 8 and cytokeratin 18. J Protein Chem. 1999; 17(8):845-54. DOI: 10.1023/a:1020738620817. View